INTERVASCULAR, SAS vs Philips North America: FDA Enforcement Comparison

Philips North America has been the subject of 357 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for INTERVASCULAR, SAS.

INTERVASCULAR, SAS: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.

Philips North America: 0 warning letters, 357 recalls, 0 approval records, 0 Form 483s.

Side by side

INTERVASCULAR, SAS — Warning letters0

Philips North America — Warning letters0

INTERVASCULAR, SAS — Recalls1

Philips North America — Recalls357

INTERVASCULAR, SAS — Approval records0

Philips North America — Approval records0

INTERVASCULAR, SAS — Form 483s0

Philips North America — Form 483s0

Timeline

INTERVASCULAR, SAS

Most recent FDA action: September 30, 2026

Full history →

Philips North America

Most recent FDA action: September 23, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"INTERVASCULAR, SAS vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed October 12, 2026. https://argushq.ai/compare/intervascular-sas-vs-philips-north-america

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗